Steroids Reduce the Efficacy of Mesenchymal Stem Cell Therapy for Liver Cirrhosis
X. Chen,Y. Gan,Y. Wang,Y. Shi
DOI: https://doi.org/10.1016/j.jcyt.2015.03.477
IF: 6.196
2015-01-01
Cytotherapy
Abstract:Mesenchymal stem cell (MSC) transplantation is becoming a novel therapy for many degenerative diseases and immune disorders. However, the clinical outcomes of MSC-based therapy are inconsistent, especially when steroids, most popular immunosuppressants, are co-administered in clinical practice. To examine whether steroids interfere with the therapeutic effects of MSCs, we employed mice with carbon tetrachloride (CCl4)-induced liver cirrhosis and found that while MSCs alone were effective, concurrent administration with dexamethasone (Dex) abrogated the therapeutic effects of MSCs on liver fibrin deposition, serum levels of bilirubin, albumin and aminotransferases, as well as T lymphocyte infiltration, especially IFN-g+CD4+ and IL-17A+CD4+T cells. Furthermore, Dex reversed the immunosuppressive effect of MSCs and prevented the induction of inducible nitric oxide synthase (iNOS) through affecting STAT1 phosphorylation. Interestingly, the induction of chemokines in MSCs was unaffected. Likewise, iNOS-/-MSCs, which produce chemokines but not nitric oxide (NO) under inflammatory conditions, are ineffective in treating liver cirrhosis. In our pilot clinical study, although MSC-treated patients suffering from decompensated liver cirrhosis exhibited significant recovery, those received MSCs and steroids concurrently did not show improvement in liver function and inflammatory status. Therefore, MSC-mediated therapy requires pre-existing inflammation and concomitant application of MSCs with steroids should be avoided in clinical settings. Figure 2Dexamethasone abolished the anti-inflammatory effect of MSCs. (A) On day 63, Serum levels of IFN-g, TNF-a, IL-1b, and IL-12 in each group were assayed by Luminex technology. (B) On day 67, some mice were euthanized and liver sections from each group were stained with hematoxylinandeosin (100 × magnification). (C) Quantitative analysis of lymphoid infiltration in liver sections was carried out as described in Materials and Methods, and percentage of area affected by inflammatory infiltration was calculated. (D) Flow cytometric analysis of IFN-g+, IL-17A+ and Foxp3+CD25+ T cells (CD4+) in liver. (E) Quantitative analysis of IFN-g+CD4+, IL-17A+CD4+ T cells and Foxp3+CD25+CD4+cells T in liver. Values are shown as mean±SEM, and statistical significance indicated as ∗p<0.05,∗∗p<0.01, and ∗∗∗p<0.001. Representative of three independent experiments; n= 7-10. View Large Image Figure Viewer Figure 3Dexameth a sone completely reversed the immunosuppressive effects of MSCs in vitro. Splenocytes from C57BL/6 mice were co-cultured with MSCs from WT C57BL/6 mice (1:20 ratio of MSC to splenocytes) in the presence of anti-CD3, with or without Dex, and proliferation was assayed by 3H-Tdr incorporation. (B) Total nitrates in the supernatant of the cultures from (A) were assayed by modified Griess reagent. (C-D) Proliferation of human PBMCs co-cultured with human MSCs (1:10 ratio of MSCs to PBMCs) in the presence of anti-CD3 and anti-CD28, with or without dexamethasone or methylprednisolone, respectively. Values are shown as mean±SEM. Representative of five independent experiments. View Large Image Figure Viewer